Lifestyle Intervention for Cardiovascular Disease and Type 2 Diabetes
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It focuses on lifestyle changes, so it's best to discuss your medications with the trial coordinators or your doctor.
Research shows that family-based interventions, especially those culturally tailored, can improve self-management and reduce distress in individuals with type 2 diabetes. These interventions have shown sustained improvements in diet and exercise management, which are crucial for managing diabetes and potentially beneficial for cardiovascular health.
12345The studies on family-based lifestyle interventions for diabetes, particularly among Latino families, suggest that these interventions are generally safe. They focus on education, social support, and self-management, which are non-invasive and promote healthy behaviors.
12346The Family Dyad Intervention is unique because it involves the patient's family in the treatment process, focusing on family engagement, empowerment, and support to improve lifestyle habits and manage health conditions. This approach is culturally tailored and emphasizes the role of family dynamics in promoting health, which is different from traditional individual-focused treatments.
12378Eligibility Criteria
This trial is for adults over 18 living in rural Kentucky, with internet access and at risk for type 2 diabetes or cardiovascular disease. Participants must speak English or Spanish and may include a family member who lives nearby. Those with cognitive impairments, major psychiatric conditions, pregnancy, or known heart diseases are excluded.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive eight weekly educational sessions focused on self-management of risk factors and engagement in healthy behaviors for risk reduction
Follow-up
Community health workers follow up with participants once a month by phone to monitor long-term impact on type 2 diabetes and CVD risk factors